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ABSTRACT. Cortienic acid was obtained by periodic acid oxidation of fluocinolone 
acetonide, whereas corresponding amide was synthesized from the cortienic acid and 
ethyl ester of β-alanine by dicyclohexylcarbodiimide – hydroxybenzotriazole coupling 
procedure. Lipophilicity of the amide was evaluated by using reversed-phase thin-layer 
chromatography systems, consisting of ethanol and water in various ratios, and was 
higher in comparison to fluocinolone acetonide and cortienic acid.  
 






The soft drug concept was presented as part of retrometabolic drug design approach, 
whose aim was to obtain biologically active compounds with fewer side effects (BODOR et al., 
1980; BODOR and KAMINSKI, 1980; STAŃCZAK et al., 2006; PROCOPIOU et al., 2010). The first 
and second generations of soft glucocorticoids (loteprednol etabonate, etiprednol dicloacetate 
and corresponding analogues) are cortienic acid derivatives, which are inactive and non-toxic 
metabolites of traditional glucocorticoids (BODOR and BUCHWALD, 2006; PAVESIO et al., 
2008; CHANDEGARA and CHORAWALA, 2012). Other glucocorticoid derivatives which are 
easily metabolized after local administration to non-toxic and inactive metabolites could also 
be considered soft drugs (antedrugs) (KHAN and LEE, 2008).  
Novel amides of cortienic acids (derived from hydrocortisone, prednisolone, 
methylprednisolone, dexamethasone and betamethasone) and esterified amino acids (methyl 
and ethyl esters of L-glycine, methyl ester of L-alanine, ethyl ester of β-alanine and methyl 
ester of L-phenylalanine) have been recently presented as potentially new soft glucocorticoids 
for local application to the skin. Their permeability and retention in the skin were predicted by 
using parallel artificial membrane permeability assay (PAMPA) and biopartitioning micellar 
chromatography. Quantitative structure – permeability relationship (QSPR) and quantitative 
structure – retention relationship (QSRR) analyses underlined lipophilicity as a physico-
chemical property with the highest positive influence on permeability and retention 
(DOBRIČIĆ et al., 2014; DOBRIČIĆ et al., 2014a). The presence of L-glycine, L-alanine and β-
alanine residues in the 17β side chain enables favorable molecule orientation and key binding 
interactions with amino acids in the glucocorticoid receptor, which was confirmed by good 
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local anti-inflammatory activity of these derivatives. Therefore, good local anti-inflammatory 
activity of novel soft glucocorticoids containing these amino acids in the 17β side chain could 
be expected. Additionally, fewer systemic side effects (in comparison with dexamethasone) 
and predicted metabolic inactivation indicate that these compounds could be classified as 
novel soft glucocorticoids (DOBRIČIĆ et al., 2014b). 
The aim of this study was to synthesize a new soft glucocorticoid, which is amide of 
fluocinolone acetonide – derived cortienic acid and ethyl ester of β-alanine. Lipophilicity of 
the amide was evaluated by using reversed-phase thin-layer chromatography (RP-TLC) and 
compared to fluocinolone acetonide and cortienic acid.  
 
 
MATERIALS AND METHODS 
 
Chemicals and apparatus 
Fluocinolone acetonide (FA) was purchased from Tokyo Chemical Industry (Tokyo, 
Japan) and dioxane from Carlo Erba (Rodano, Italy). N-hydroxybenzotriazole (HOBt), N,N′-
dicyclohexylcarbodiimide (DCC), N,N-dimethylformamide (DMF) and silica gel for 
preparative thin-layer chromatography were purchased from Sigma Aldrich (Steinheim, 
Germany), whereas triethylamine (TEA) was bought from Fisher Scientific (Loughborough, 
UK). β-alanine ethyl ester hydrochloride and periodic acid were purchased from Acros 
Organics (Geel, Belgium). Chloroform, ethanol 96% and methanol were purchased from JT 
Baker (Loughborough, UK) and acetone was bought from Zorka (Šabac, Serbia). Silica gel 
for column chromatography and RP-18 modified silica gel TLC plates with F254 fluorescent 
indicator were purchased from Merck (Darmstadt, Germany). 
Melting points were determined by using Boetius PHMK 05 apparatus (Radebeul, 
Germany). The 1H NMR spectra were recorded on an NMR BRUKER AVANCE III 400 
spectrometer (Bruker Biospin GmbH, Rheinstetten, Germany), operating at 400 MHz. The 
accurate masses were determined by using Agilent 6210 Time-of-Flight mass spectrometer 
(Agilent Technologies, Palo Alto, CA, USA), whereas IR spectra were recorded by using 
ATR-FTIR spectrometer Nicolet iS10 (Thermo Scientific, Madison, WI, USA). MS/MS 
analyses were performed on TSQ Quantum Access MAX triple quadrupole mass spectrometer 
(Thermo Fisher Scientific, San Jose, USA), equipped with heated electrospray ionization 
source (HESI). 
 
Synthesis of cortienic acid (CFA) 
Fluocinolone acetonide (300 mg, 0.66 mmol, 1 eq) was dissolved in dioxane (2 mL). 
Solution of periodic acid in water (275 mg mL -1) was added dropwise (0.6 mL, 0.72 mmol of 
periodic acid, 1.1 eq). The reaction mixture was stirred at room temperature for 20 h and 
evaporated to dryness under reduced pressure. The crude product was washed with water (5 
mL), dried, washed with chloroform (12 mL) and dried again.  
 
Synthesis of amide (FAEA) 
CFA (61 mg, 0.14 mmol, 1 eq) was dissolved in DMF (2 mL) and the solution was 
cooled at 0 oC. Subsequently, DCC (58 mg, 0.28 mmol, 2 eq) and HOBt (29 mg, 0.21 mmol, 
1.5 eq) were added. The mixture was stirred at the same temperature for 1 h and after that it 
was maintained at temperature not exceeding 8 oC for 20 h. β-alanine ethyl ester 
hydrochloride (22.2 mg, 0.14 mmol, 1 eq) was dissolved in DMF (1 mL), TEA was added (39 
µL, 0.28 mmol, 2 eq) and this mixture was cooled at 0oC. Finally, the mixture of CFA, DCC 
and HOBt was filtered and added dropwise. The final reaction mixture was stirred at 0oC for 1 




filtered, evaporated to dryness under reduced pressure and purified by using column 
chromatography (the mobile phase was chloroform/methanol 99:1 (v/v)). Final purification 
was performed using preparative thin layer chromatography (the mobile phase was 
chloroform/methanol 95:5 (v/v)). The purified compound was recrystallized in the mixture of 
water and methanol.  
 
RP-TLC evaluation of lipophilicity 
The TLC plates were spotted with 1.0 µL of freshly prepared solutions of tested 
compounds in ethanol (1 mg mL-1) and developed by the ascending technique in glass TLC 
chambers with glass lids. After development, spots were detected under UV light (λ=254 nm). 
The RF values were calculated according to the equation (1): 
                                                                                                                               (1) 
l - migration distance of tested compound 
l0- migration distance of solvent front 
 
The RM values were calculated according to the equation (2). 
 





Synthesis and physico-chemical characterization of CFA 
 
After purification, white crystalline solid was obtained (127 mg, yield: 44%, Fig. 1).  
Melting point: 263.5-266 oC. IR (ATR) νmax (cm-1): 710.64, 728.48, 852.11, 863.13, 913.54, 
1054.11, 1161.50, 1172.02, 1254.61, 1376.61, 1385.47, 1612.62, 1603.02, 1661.27, 1711.48, 
1722.46, 3409.29. 1H NMR (400 MHz, CD3OD) δ ppm 1.06 (3H, s, H-18), 1.25 (3H, s, CH3 
from C16α, C17α side chain), 1.35 (3H, s, CH3 from C16α, C17α side chain), 1.56 (5H, m, 
3xH-19, 2xH-12), 1.71 (1H, m, H-7), 1.79 (1H, d, J=13.6 Hz, H-15), 2.07 (2H, m, H-14, H-
15), 2.30 (1H, m, H-8), 4.24 (1H, d, J=10 Hz, H-11), 5.52 (1H, m, H-6), 6.27 (1H, s, H-4), 
6.32 (1H, dd, J=2 Hz, J=10 Hz, H-2), 7.37 (1H, d, J=10.4 Hz, H-1). m/z = 436.9 (M+-1), 
334.9, 416.9, 266.8, 294.8, 314.8, 276.8. MS [M+H]+ calculated for C23H28F2O6= 438.18539; 








Synthesis and physico-chemical characterization of FAEA 
 
After purification, white crystalline solid was obtained (53 mg, yield: 70%, Fig. 2). 
Melting point: 237.2−239.9 oC. IR (ATR) νmax (cm-1): 863.64, 898.23, 993.38, 1030.80, 
1044.54, 1061.43, 1193.36, 1351.52, 1376.79, 1520.94, 1635.39, 1671.17, 1723.06, 3441.62. 
1H NMR (400 MHz, DMSO-d6) δ ppm 0.86 (3H, s, H-18), 1.10 (3H, s, CH3 from C16α, 
C17α side chain), 1.19 (3H, t, J=7.2 Hz, R-NH-CH2CH2C(=O)OCH2CH3), 1.32 (3H, s, CH3 
from C16α, C17α side chain), 1.50 (3H, s, 3xH-19), 1.54 (4H, m, H-7, H-15, 2xH-12), 1.95 
(3H, m, H-14, 2xH-15), 2.27 (1H, m, H-8), 4.06 (2H, q, J=7.2, R-NH-
CH2CH2C(=O)OCH2CH3), 4.16 (1H, m, H-11), 4.94 (1H, m, H-16), 5.43 (1H, s, -OH at C-
11), 5.57 (1H, m, H-6), 6.11 (1H, s, H-4), 6.30 (1H, dd, J=2 Hz, J=10 Hz, H-2), 7.27 (1H, d, 
J=10 Hz, H-1), 7.77 (1H, t, J=6 Hz, R-NH-CH2CH2C(=O)OCH2CH3). m/z = 536.0 (M+-1), 
516.1, 415.8, 395.9, 435.8, 276.8, 427.8. MS [M+H]+ calculated for C28H37F2NO7 = 




Figure 2. Synthesis of FAEA 
 
RP-TLC evaluation of lipophilicity 
 
Chromatographic behavior of FAEA, FA (parent glucocorticoid) and CFA 
(intermediate in the FAEA synthesis and potential metabolite of FAEA) was tested in four 
RP-TLC systems, consisting of ethanol and water in different ratios: 40:50, 50:50, 60:40 and 
70:30 (v/v). For each compound, RM values were calculated and plotted against the 
percentage of ethanol (Fig. 3). 
 
RP-TLC parameters, used for the evaluation of lipophlicity of FA, CFA and FAEA, 
are presented in Table 1. 
 






FA 3.17 -0.056 56.26 
CFA 2.65 -0.055 48.01 













Synthesis of CFA and FAEA 
Periodic acid oxidation is the most commonly used procedure for the synthesis of 
cortienic acids. In this study, CFA was synthesized by periodic acid oxidation of fluocinolone 
acetonide and the highest yield was obtained when dioxane was used as a solvent. 
Alternatively, oxidation could be performed by introducing air in the solution of fluocinolone 
acetonide in the presence of potassium-carbonate or by using potassium superoxide 
(ALVAREZ, 1980; ASHTON et al., 1994).  
FAEA was synthesized by using two-step DCC-HOBt coupling procedure, which 
resulted in higher yields than the single-step EDC-HOBt coupling procedure when similar 
compounds were synthesized (DOBRIČIĆ et al., 2014b). In the first step, CFA was esterified 
with HOBt (in the presence of DCC) and in the second step FAEA was synthesized in the 
reaction between CFA-HOBt ester and ethyl ester of β-alanine (FORMSTECHER et al., 1980).  
 
RP-TLC evaluation of lipophilicity 
The shake flask method, based on partitioning of substances between octanol and 
water, is considered standard method for the estimation of lipophilicity. However, it is time 
consuming and requires large amounts of solvents and tested compounds. Alternatively, 
chromatographic methods (HPLC and TLC) can be used for fast and simple evaluation of 
lipophilicity of various groups of drugs (MAES et al., 1998; CSERMELY et al., 2008; ODOVIĆ et 
al., 2009).   
RP-TLC parameters used for the estimation of lipophilicity were C0 (RM value when 
the ethanol content is 0% (curve intercept)), a (slope of the curve) and  (MORAK et al., 
2007; STAREKA et al., 2013; BIEGANOWSKA et al., 1995). Correlation coefficients ranged 
from 0.9889 to 0.9995, which means there are linear relationships between RM values and 
ethanol contents. Therefore,  can be calculated by extrapolation of the curves to the y 
axes. Parameter  is calculated according to the equation (3): 
 
                                                                                                                          (3) 
 
FAEA has the highest values of  and and the highest absolute value of a, 
indicating higher lipophilicity of this derivative in comparison with FA and CFA. Therefore, 





Cortienic acid was synthesized by periodic acid oxidation of fluocinolon acetonide 
(yield: 44%) and used for the synthesis of amide with ethyl ester of β-alanine (DCC-HOBt 
coupling procedure; yield: 70%). Chromatographic behavior of fluocinolone acetonide, 
cortienic acid and the amide was tested in RP-TLC systems consisting of ethanol and water in 
various ratios (40:50, 50:50, 60:40 and 70:30 (v/v)). Calculated RP-TLC parameters ( , a 
and ) indicate that FAEA should have the highest lipophilicity and favorable properties for 








This work was financially supported by the Ministry of Education, Science and 





[1]  ALVAREZ, F.S. (1980): Chemical process for preparing androsta-4-ene 17α-carboxilic 
acid. US 4198336 A. 
[2]  ASHTON, M.J., KARLSSON, S.J.-A., VACHER, B.Y.J., WITHNALL, M.T. (1994): New 
steroids. WO 94/14834. 
[3]  BIEGANOWSKA, M.L., DORACZYNSKA-SZOPA, A., PETRUCZYNIK, A. (1995): The 
retention behavior of some sulfonamides on different TLC plates. 2. Comparison of the 
selectivity of the systems and quantitative determination of hydrophobicity parameters. 
J. Planar Chromatogr. - Mod. TLC 8: 122-128. 
[4]  BODOR, N., KAMINSKI, J., SELK, S. (1980): Soft drugs. 1. Labile quaternary ammonium 
salts as soft antimicrobials. J. Med. Chem. 23: 469-474. 
[5]  BODOR, N., KAMINSKI, J. (1980): Soft drugs. 2. Soft alkylating compounds as potential 
antitumor agents. J. Med. Chem. 23: 566-569. 
[6]  BODOR, N., BUCHWALD P. (2006): Corticosteroid design for the treatment of asthma: 
structural insights and the therapeutic potential of soft corticosteroids. Curr. Pharm. 
Des. 12: 3241-3260. 
[7]  CHANDEGARA, N., CHORAWALA, M (2012): Soft and dissociative steroids: a new 
approach for the treatment of inflammatory airway and eye diseases. Int. J. Pharm. Sci. 
Res. 3: 311-319. 
[8]  CSERMELY, T., KALASZ, H., DEAK, K., HASAN, M., DARVAS, F., PETROIANU, G. (2008): 
Lipophilicity determination of some ACE inhibitors by TLC. J. Liq. Chromatogr. R. T. 
31: 2019-2034. 
[9]  DOBRIČIĆ, V., MARKOVIĆ, B., NIKOLIC, K., VLADIMIROV, S., ČUDINA, O. (2014): 17β-
carboxamide steroids – in vitro prediction of human skin permeability and retention 
using PAMPA technique. Eur. J. Pharm. Sci. 52: 95-108. 
[10]  DOBRIČIĆ, V., NIKOLIC, K., VLADIMIROV, S., ČUDINA, O. (2014a): Biopartitioning 
micellar chromatography as a predictive tool for skin and corneal permeability of newly 
synthesized 17β-carboxamide steroids. Eur. J. Pharm. Sci. 56: 105-112. 
[11]  DOBRIČIĆ, V., MARKOVIĆ, B., MILENKOVIĆ, N., SAVIĆ, V., JAĆEVIĆ, V., RANČIĆ, N., 
VLADIMIROV, S., ČUDINA, O. (2014b): Design, synthesis, and local anti-inflammatory 
activity of 17β-carboxamide derivatives of glucocorticoids. Arch. Pharm. 347: 786-797. 
[12]  FORMSTECHER, P., LUSTENBERGER, P., DAUTREVAUX, M. (1980): Synthesis of steroidal 
17β-carboxamide derivatives. Steroids  35: 265-272. 
[13]  KHAN, M.O.F., LEE, H.J. (2008): Synthesis and pharmacology of anti-inflammatory 
steroidal antedrugs, Chem. Rev. 108: 5131-5145. 
114 
 
[14]  MAES, P., FORMSTECHER, P., LUSTENBERGER, P., DAUTREVAUX, M (1998): High-
performance liquid chromatography in the evaluation of the lipophilicity of 17β-
carboxamide steroid derivatives. J. Chromatogr. 445: 409-416.   
[15]  MORAK, B., NOWAK, M., PLUTA, K. (2007): Determination of the lipophilicity 
parameters RM0 and LogP of new azaphenothiazines by reversed‐phase thin‐layer 
chromatography. J. Liq Chromatogr. R. T. 30: 1845-1854. 
[16]  ODOVIĆ, J., ALEKSIĆ, M., STOJIMIROVIĆ, B., MILOJKOVIĆ-OPSENICA, D., TEŠIĆ, Ž. 
(2009): Normal-phase thin-layer chromatography of some angyotensin converting 
enzyme (ACE) inhibitors and their metabolites. J. Serb. Chem. Soc. 74: 677-688. 
[17]  PAVESIO, C. E., DECORY, H. H. (2008): Treatment of ocular inflammatory conditions 
with loteprednol etabonate. Br. J. Ophthalmol. 92: 455-459. 
[18]  PROCOPIOU, P.A., BARRETT, V.J., BEVAN, N.J., BIGGADIKE, K., BOX, P.C., BUTCHERS, 
P.R., COE, D.M., CONROY, R., EMMONS, A., FORD, A.J., HOLMES, D.S.,  HORSLEY, H., 
KERR, F., LI-KWAI-CHEUNG, A.M., LOOKER, B.E., MANN, I.S., MCLAY, I.M., 
MORRISON, V.S., MUTCH, P.J., SMITH, C.E., TOMLIN P. (2010): Synthesis and structure-
activity relationships of long-acting β2 adrenergic receptor agonists incorporating 
metabolic inactivation: an antedrug approach. J. Med. Chem. 53: 4522-4530. 
[19]  STAŃCZAK, A., FERRA, A. (2006): Prodrugs and soft drugs. Pharmacol. Rep. 58: 599-
613. 
[20]  STAREKA, M., KOMSTA, Ł. and KRZEK, J. (2013): Reversed-phase thin-layer 
chromatography technique for the comparison of the lipophilicity of selected non-
steroidal anti-inflammatory drugs. J. Pharmaceut. Biomed. 85: 132-137. 
